Genentech is poised for an anti-cancer breakthrough.
Hoyle
R
R
D001943:Breast Neoplasms / Q000188:drug therapy / Q000628:therapy*; D003131:Combined Modality Therapy; D004345:Drug Industry; D015316:Genetic Therapy; D006801:Humans; D007167:Immunotherapy; D014481:United States; D014486:United States Food and Drug Administration